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Background: XylS is the positive regulator of the inducible Pm promoter, originating from Pseudomonas putida,
where the system controls a biochemical pathway involved in degradation of aromatic hydrocarbons, which also
act as inducers. The XylS/Pm positive regulator/promoter system is used for recombinant gene expression and the
output from Pm is known to be sensitive to the intracellular XylS concentration.
Results: By constructing a synthetic operon consisting of xylS and luc, the gene encoding luciferase, relative XylS
expression levels could be monitored indirectly at physiological concentrations. Expression of XylS from inducible
promoters allowed control over a more than 800-fold range, however, the corresponding output from Pm covered
only an about five-fold range. The maximum output from Pm could not be increased by introducing more copies
of the promoter in the cells. Interestingly, a previously reported XylS variant (StEP-13), known to strongly stimulate
expression from Pm, caused the same maximum activity from Pm as wild-type XylS at high XylS expression levels.
Under uninduced conditions expression from Pm also increased as a function of XylS expression levels, and at very
high concentrations the maximum activity from Pm was the same as in the presence of inducer.
Conclusion: According to our proposed model, which is in agreement with current knowledge, the regulator, XylS,
can exist in three states: monomers, dimers, and aggregates. Only the dimers are active and able to induce
expression from Pm. Their maximum intracellular concentration and the corresponding output from Pm are limited
by the concentration-dependent conversion into inactive aggregates. Maximization of the induction ratio at Pm can
be obtained by expression of XylS at the level where aggregation occurs, which might be exploited for recombinant
gene expression. The results described here also indicate that there might exist variants of XylS which can exist at
higher active dimer concentrations and thus lead to increased expression levels from Pm.
Keywords: XylS, Pm, Recombinant gene expression, Induction ratioBackground
Regulated promoters are commonly used in recombin-
ant protein production processes and are particularly
important for production of host-toxic proteins or pro-
teins that cause a serious metabolic burden to the host
cells [1,2]. The transcription regulator XylS stimulates ex-
pression from the Pm promoter in the presence of benzoic
acid or derivatives thereof [3]. XylS originates from the
Pseudomonas putida TOL-plasmid and is expressed from
two different promoters, Ps1 and Ps2: Ps1 is regulated,* Correspondence: rahmi.lale@ntnu.no
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reproduction in any medium, provided the orwhile Ps2 is constitutive [4]. The production level of XylS
from Ps2 is low, leading to an estimated amount of about
200 molecules per cell [5].
XylS belongs to the AraC/XylS family of transcription
factors and it has been shown to be transcriptionally ac-
tive as a dimer. Dimerization occurs both in the absence
and presence of inducer, but to a greater extent in its
presence [5,6]. In spite of sequence similarities and com-
mon functional domains, the different members of the
AraC/XylS family act via a range of different mecha-
nisms. AraC, for example, forms dimers like XylS, both
in the presence and absence of inducer [7]. In the pres-
ence of inducer it acts as an activator of gene expression
(like XylS), but in the absence of inducer, it repressestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Map of plasmid pFS7. Ps2: constitutive promoter; xylS:
gene encoding Pm activator; luc: gene encoding luciferase; Pm:
positively regulated promoter; bla: ampicillin resistance gene
encoding β-lactamase; t1: rrnBT1T2 bidirectional transcriptional
terminator; trfA: gene encoding the replication protein; oriV: origin
of vegetative replication; kan: kanamycin resistance gene; oriT: origin of
conjugal transfer. The DNA sequence of the overlapping stop-start
codon is depicted.
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of the AraC/XylS family, for which 3D crystal structures
have been determined, were RobA and MarA, and both
exist as monomers only [8].
XylS consists of two domains and structural models
exist for both, constructed based on sequence align-
ments [9,10]. The model of the N-terminal domain pro-
poses a β-barrel, which is involved in inducer binding
and two α-helices that probably are involved in dimerization
[10-12]. In the C-terminal domain seven α-helices that form
two helix-turn-helix motifs are proposed [9]. These motifs
are responsible for binding to two direct repeats with the se-
quence TGCAN6GGNTA upstream of the −35 box of Pm
[13,14]. The second binding site overlaps by two bases with
the −35 box and this overlap is essential for transcription
initiation from Pm [15]. Both domains are thought to inter-
act with the host RNA polymerase (RNAP) [16-19].
The N-terminal domain has been shown to suppress
the action of the C-terminal domain in the absence of
inducer [5,20]. Binding of wild type XylS to DNA can
only be observed when the protein is dimerized [5]. A
XylS-variant which is unable to form dimers has been
shown to bind to DNA only in the presence of inducer,
which leads to the same conformational changes as
dimerization, however, this particular variant is unable
to activate expression from Pm [5]. Recently it has been
shown that XylS dimers bind to DNA sequentially. The
first monomer to bind is the one proximal to the RNAP
binding site. This leads to [10DNA bending, which in
turn enables the second monomer to bind, and indicates
that XylS is dimerized prior to DNA binding [16]. At
typical cell-internal XylS-levels only 30-40% of the Pm
promoter sequences are occupied in vitro and it has
been proposed that complete occupancy cannot be
achieved by XylS amounts which do not exceed its intra-
cellular solubility [21].
Vectors which combine the XylS/Pm expression system
with the broad-host-range mini-RK2 replicon [22,23], in
which XylS is expressed from its natural Ps2 promoter,
have been shown to be capable of producing recombinant
proteins at industrial levels in Escherichia coli [24,25]. Ex-
pression levels of these vectors could be heavily increased
by mutating different DNA control elements of the ex-
pression cassette [10,26,27], and recently it has been dem-
onstrated that they could be yet further improved when
mutated DNA elements were combined [28]. When in-
duced expression levels are increased it leads, in most
cases, to undesired high expression levels also in the ab-
sence of inducer. For the XylS/Pm expression system the
background expression could be strongly reduced when
the 5′-UTR flanking the Shine-Dalgarno site was muta-
genized and this has been demonstrated to be useful for
metabolic engineering purposes [29]. With this approach
an induction ratio of 260-fold could be reached, however,as a consequence induced expression levels were also re-
duced for these constructs. A possible alternative method
of reducing uninduced expression could be to regulate the
XylS expression level. Previous experiments have shown
that strong XylS overexpression, as for example from the
bacteriophage T7 promoter or from Ps1, results in a
complete loss of inducibility [21,30]. Fusion of xylS to
the Psal promoter, which can be activated by similar
inducers as Pm, allowed simultaneous induction of
XylS expression and XylS activation. Induction ratios
that could be reached by this approach were about
180- to 240-fold [31].
Here we report a more detailed study on the relation-
ship between XylS expression levels and expression
levels achieved from the Pm promoter, both under in-
duced and uninduced conditions. Based on the out-
comes of this study we propose a model that aims to
explain the behaviour of XylS as a function of its con-
centration and its formation of monomers, dimers and
higher order oligomers.
Results and discussion
Construction of a synthetic operon that can be used to
indirectly measure relative XylS expression levels
With the goal to enable detection of XylS at low concen-
trations we developed a synthetic operon in which lucif-
erase functions as an indirect indicator of expression of
XylS from its native Ps2 promoter. In this design the luc
gene is transcriptionally fused to xylS via overlapping
stop and start codons and should be translated only
when xylS is translated first. The new plasmid was desig-
nated as pFS7 (Figure 1). To test the functionality of this
construct we used a series of xylS variant sequences which
had been synthesized. These variants contain synonymous
codon changes relative to the wild type sequence and had
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ence of induction). We hypothesized that the effects of the
codon changes were caused by variations in xylS mRNA
translation, since transcript amounts were found to be
similar to the levels of the wild type gene (qRT-PCR, data
not shown). Nine such variant sequences were tested in
pFS7, and luciferase activities were measured (Figure 2).
The values varied in the range from about 20 to 100% of
that of the construct containing the wild type xylS.
The design of plasmid pFS7 also allowed us to study the
effects of the changed XylS expression on activation of
Pm. For this purpose the bla gene, encoding β-lactamase,
was used as a reporter (see Figure 1). We have previously
used this gene to monitor expression from Pm, since the
tolerance of the host to ampicillin correlates well with the
produced amounts of β-lactamase in a directly propor-
tional way [32], up to ampicillin concentrations of
16 mg mL-1, thus making it easier to identify clones with
desired phenotype without laborious library screening
[10,26,27]. The data for luciferase activities and host ampi-
cillin tolerances on agar medium correlated well (Figure 2).
As an additional control we compared the ampicillin tol-
erances of all the nine constructs (and wild type) to those
in plasmid pTA13 (similar to pFS7, but without luc), and
found that the relative maximum ampicillin tolerances be-
tween the corresponding hosts were essentially the same
(data not shown). These results indicate that luciferase
activities reflect the levels of XylS expression in the
cells, and that the activity of Pm also correlates withFigure 2 Expression levels from pFS7 for different variants of xylS wit
maximum ampicillin tolerance at 1 mMm-toluate) are given in grey (error
was observed) and relative luciferase activity as a measure for XylS amount
(relative ampicillin tolerance and luciferase expression) refer to those of wil
Mutations in the variants (1 to 9), the number stands for the base position
character tells the base in the variant. 1: 6- > C; 2: 13- > C; 3: 15- > G; 4: 16- >
eight mutations.XylS expression, at least at these physiological and low
concentrations.
In trans activation of expression from Pm by XylS
increases the induction ratio
The XylS concentrations that could be generated via syn-
onymous codon variants spanned only a five-fold range,
and none of the expression levels were significantly higher
than that of the wild type xylS gene (Figure 2). To expand
the concentration range and increase the maximum level
of expression from Pm, we expressed XylS in trans from a
separate plasmid compatible with pFS7. This plasmid was
based on the pBBR1 replicon (about five-fold higher copy
number than the mini-RK2 replicons) and the xylS gene
under its native Ps2 promoter (as in pFS7) was inserted,
generating pFZ2A. The xylS and luc genes were deleted
from plasmid pFS7 leading to pFS15. Maximum ampicillin
tolerances of cells containing both pFZ2A (expressing
xylS-luc) and pFS15 (harboring Pm) were approximately
5 μg mL-1 (uninduced) and 2500 μg mL-1 (induced with
1 mMm-toluate), which gives rise to an induction ratio as
high as about 500-fold. The increase in ampicillin toler-
ance in the presence of m-toluate, compared to the setting
where XylS is expressed in cis (pFS7, 350 μg mL-1), was
not unexpected and might be explained by the higher
copy number of plasmid pFZ2A relative to pFS7, leading
to more XylS expression. In contrast, the uninduced back-
ground level (expression from the promoter in the ab-
sence of induction) remained significantly lower in theh silent mutations. Relative expression levels from Pm (measured as
bars = lowest ampicillin concentrations in test on which no growth
s in black (values from at least two biological replicas). All values
d type XylS (tolerating 350 μg mL-1), which are both arbitrarily set to 1.
that has been changed, relative to the translational start site, the
C; 5: 27- > G; 6: 30- > C; 7: 36- > T; 8: 42- > T; 9: all of the
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lar to the cellular background tolerance in the absence of
any plasmid. This phenomenon might be explained by the
fact that XylS will dimerize only occasionally in the ab-
sence of inducer. Probably the concentration of XylS and
consequentially also dimers of the protein is highest near
the site of synthesis. The larger spatial distance from Pm
in the trans situation will then lead to a lack of dimers at
the promoter site. In the cis situation the chance of XylS
dimers to bind to Pm will be higher, as the protein is pro-
duced in close proximity to the promoter. The lower
background level in the trans situation may be of practical
interest, for example in cases where expression from Pm
is maximized by mutations in the expression cassette [28],
and especially for expression of toxic proteins. In the con-
text of the experiments reported here, the in trans system
seems clearly well suited for more in-depth studies of the
relation between XylS expression and activation of Pm in
the absence and presence of induction.
Use of the regulated Pb promoter to control the xylS
expression level
The experiments described above as well as previously
published studies [21,31] demonstrate that expression
from Pm can be increased by producing more XylS, and
to determine what the maximum level is we decided to
use the inducible Pb promoter from Acinetobacter sp. to
express XylS. Pb, like Pm, can be used to regulate ex-
pression of genes in a continuously graded manner [33].
It is positively regulated by the ChnR protein, which also
belongs to the AraC/XylS transcription factor family, in
the presence of its inducer cyclohexanone. The xylS-luc
operon expressed from Pb and the gene of the activator
protein, chnR, were cloned into pBBR1MCS-5 [34], gen-
erating pFZ2B1, and pFS15 was used as target plasmid
for XylS harboring the Pm promoter, as described above.
Cells containing both of these plasmids were plated on
agar medium, supplemented with varying amounts of
ampicillin, cyclohexanone and m-toluate. As expected,
cells with only one of the two plasmids (either pFZ2B1
or pFS15) reacted only marginally to the addition of the
inducers. However, in the presence of both plasmids the
ampicillin tolerance of the host cells varied as a function
of both the cyclohexanone and m-toluate concentra-
tions. At a fixed 1 mM m-toluate concentration the host
ampicillin tolerance correlated well with both the con-
centration of cyclohexanone and the luciferase activity,
which reflects XylS expression (Figure 3, grey squares).
However, at the two highest concentrations of cyclohex-
anone tested (1 and 2 mM) the upper ampicillin toler-
ances were similar (3500 μg mL-1) and about 5.4 times
higher than in the absence of the Pb inducer.
The results presented above might indicate that ex-
pression from Pm could not be stimulated more byfurther increasing the XylS expression. We have on the
other hand observed that 2 mM cyclohexanone is not so
far from concentrations that have observable negative ef-
fects on cell growth [34], and we therefore wanted to
create conditions at which XylS expression could be in-
creased further without using near-toxic concentrations
of cyclohexanone. In a parallel ongoing project we had
observed that the expression level from the Pb promoter
is, like Pm, very sensitive to the amounts of its regulator,
ChnR. This was taken advantage of by substituting the
chnR native promoter with constitutive promoters from
the Registry of Standard Biological Parts, which were
identified by a library screening [35]. Two promising
variants were used to drive chnR expression in deriva-
tives of pFZ2B1, namely pFZ2B2 and pFZ2B3, such that
XylS expression could be controlled by cyclohexanone,
as above, but hopefully at higher levels. As expected this
resulted in increased XylS expression (measured as lucif-
erase activity), up to 50-fold (pFZ2B3) above the max-
imum for pFZ2B1. In spite of this, the expression from
Pm (in pFS15) was not higher than when pFZ2B1 was
used for expression of XylS (Figure 4a,c and d, grey
squares).
For studies of expression from Pm in the absence of
m-toluate (see further down) we also expressed xylS
from the very strong bacteriophage T7 promoter (in
plasmid pET16.xylS), heavily used for recombinant pro-
tein production. Activation of the T7 promoter requires
the presence of T7 RNAP, and its production is induced
by isopropyl β-D-1-thiogalactopyranoside (IPTG). In the
presence of this inducer XylS expression (measured as
luciferase activity) was increased about five-fold com-
pared to the maximum achieved by pFZ2B3, but the cor-
responding host tolerance to ampicillin did not increase
any further (Figure 4e). Since we know that the ampicil-
lin tolerance of the host can be increased to much
higher levels by other means [28] we concluded that by
using pFS15 as target plasmid for XylS, expression of the
reporter (bla) downstream of Pm cannot be increased
beyond the identified maximum (3500 μg mL-1) by en-
hancing production of XylS.
The XylS variant StEP-13 stimulates expression from Pm
to the same maximum level as wild type XylS
In a previous study in our laboratory variants of xylS
were isolated that resulted in strongly stimulated expres-
sion from Pm [10]. One such variant (StEP-13), which
contains five amino acid substitutions (F3Y, I50T, F97L,
E195G, M196T [10]) and originated from a combination
of error-prone PCR and DNA shuffling procedures, was
subjected to a comparative analysis with wild type xylS.
This was done by first substituting the wild type xylS in
pFS7 with the variant gene. Both xylS transcript
amounts and luciferase activity were found to be the
Figure 3 Effects of variations in wild type or variant XylS expression on Pm activity. Upper host ampicillin tolerance levels as a function of
the expression level of wild type XylS (pFZ2B1) or variant StEP-13 (pFZ2B1.StEP-13), using two different copy number variants (pFS15 and
pFS15.271) of the target plasmid. Pm activity was measured as upper relative ampicillin tolerance on agar medium. The tolerance for cells containing
pFZ2B1 + pFS15, no cyclohexanone, was arbitrarily set to 1 and corresponds to about 650 μg mL-1 ampicillin resistance. The relative XylS expression
was measured as luciferase activity and was also set to 1 for the same data point. The data points indicate the highest ampicillin concentration on
which growth occurred, while the lowest concentration on which no growth was observed is indicated by error bars. Shapes that are half grey and
half black indicate identical data points for both wild type and StEP-13. 1 mMm-toluate was added to all samples, cyclohexanone concentrations
leading to the measured XylS expression levels (from left to right): 0, 0.25, 0.5, 1 and 2 mM, respectively.
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shown), indicating that the XylS expression level was
not affected by the mutations in StEP-13. Thus it was
concluded that StEP-13 increases expression from Pm
via modified functionality of the protein.
To study expression from Pm as a function of expres-
sion of StEP-13, this particular variant was placed under
control of the Pb promoter in plasmids analogous to
pFZ2B1 and pFZ2B3 (pFZ2BX.StEP-13) and transformed
into cells also containing pFS15. At low regulator ex-
pression levels cells with StEP-13, as expected, conferred
an in general higher ampicillin tolerance than cells with
wild type XylS (see Figure 3, grey and black squares).
More interestingly, the same maximum level of resist-
ance as for wild type XylS was observed, albeit it was
reached at lower regulator concentrations. No changes
in maximum resistance were found for host cells con-
taining pFZ2B3.StEP-13 either (data not shown). This
implies that the variant StEP-13 increases expression
from Pm only at sub-saturating concentrations. All muta-
tions in StEP-13 are situated in its N-terminal domain,
while the C-terminal domain is involved in DNA binding.Thus it is reasonable to assume that StEP-13 acts either
via better inducer binding, increased dimerization (which
also can be a consequence of better inducer binding),
stronger interaction with the host RNAP or a combination
of these. Improved inducer binding could be excluded as
single explanation for the phenotype of StEP-13, as the
variant increases expression from Pm quite significantly
also in the absence of m-toluate (data not shown).
The observed maximum expression level from Pm is not
caused by saturation of available XylS target DNA
binding sites
One way of explaining the observed maximum expres-
sion level is to assume that at some threshold value the
XylS amounts in the cells are sufficient to saturate all
the corresponding binding sites upstream of Pm. The
behavior of StEP-13 could then be explained by a stron-
ger affinity of the variant for binding to Pm (for example
via improved dimerization), which would lead to a satur-
ation of all binding sites at lower XylS expression levels.
This hypothesis would lead to the assumption that it
might be possible to increase expression from Pm further
Figure 4 Effects of XylS expression variations on induced and uninduced Pm activity. Upper host ampicillin tolerance levels as a function
of the expression level of XylS in the absence (white squares) and presence (grey squares) of Pm induction (0/1 mMm-toluate). The shape that is
half grey and half white represents an identical data point for both induced and uninduced. Relative expression from Pm and relative XylS
expression were determined in the same way as described in Figure 3. The data points were collected from cells containing the Pm-bearing
plasmid pFS15 in all cases and a: pFZ2B1, inducer concentrations as in Figure 3 (the grey data points are the same as the corresponding points in
Figure 3); b: pET16.xylS, 0 mM IPTG; c: pFZ2B2, 0.25 and 0.5 mM cyclohexanone (from left to right); d: pFZ2B3, 0.25 and 0.5 mM cyclohexanone
(from left to right); e: pET16.xylS, 0.5 mM IPTG.
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mid, pFSF15, which can be done by introducing specific
point mutations in the gene encoding the replication initi-
ation protein, TrfA. The positive correlation between plas-
mid copy number and level of recombinant protein
expression is well established, and we have also used it
specifically for Pm in mini-RK2 plasmids [23-25,36]. How-
ever, in previous applications the level of XylS expression
was not taken into consideration and in all reported ex-
periments the number of xylS copies was increased
equally to the number of Pm. The trfA variant cop271
leads to 3-4-fold increased plasmid copy number compared
to its wild type equivalent (4–8 copies per chromosome)
[37]. This variant was integrated into pFS15 (generating
pFS15.271) and transformed into cells, which already har-
bored pFZ2B1 or pFZ2B1.StEP-13. Host ampicillin toler-
ance was then monitored as a function of XylS expression
(luciferase activity), and the previously observed maximum
ampicillin tolerance level was found to increase only
marginally, both for wild type XylS and StEP-13, and much
less than in proportion to the expected increase in XylS
binding sites.The maximum ampicillin tolerance level also leveled
out at similar XylS expression levels as with the wild
type copy number (Figure 3, circles). Based on this we
concluded that at maximum expression from pFS15 the
limiting factor is not the number of target DNA mole-
cules for XylS binding. This is also in agreement with
previously published studies, in which the authors con-
cluded that the interactions between XylS and Pm are
too weak to lead to complete saturation [21]. Since the
number of target DNA molecules did not appear to limit
the maximum expression level from Pm we reasoned
that more likely some property of XylS was causing the
apparent saturation of the system at a certain concentra-
tion of this regulator.
In the presence of very high XylS concentrations
expression from Pm can reach the upper maximum level
in the absence of inducer
It is known that Pm looses its inducibility at high levels
of XylS expression [21,30]. As we now had a way of
varying and semi-quantitatively measuring XylS concentra-
tions we could also evaluate the response in the absence of
Figure 5 SDS-PAGE gel for XylS produced from the T7
promoter. Samples were crude bacterial lysates from cells
containing vector pET16b.xylS, grown in the presence or absence of
inducer. Samples were split into soluble and insoluble fractions. Sizes
of the protein ladder in kDa are given on the left site.
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both m-toluate and cyclohexanone cells with pFZ2B1 and
pFS15 did not tolerate significantly more ampicillin than
cells without any plasmid. As expected, the activation of
the Pm promoter was less sensitive to the presence of cy-
clohexanone than to the presence of m-toluate. This im-
plies that the induction ratio of the system becomes higher
as a function of XylS expression levels, up to the point
where the maximum expression is observed. A maximum
induction ratio of about 700 is reached at this point (about
five times more XylS expression than in the absence of cy-
clohexanone). Interestingly, above this level expression
from Pm in the absence of m-toluate continued to increase
as a function of XylS expression levels, and at the highest
production achievable with the available production tools
(induced T7 promoter, relative XylS expression about 850),
the maximum ampicillin tolerance of the host cells was at
the same level as in the presence of inducer (Figure 4e).
XylS is produced from the T7 promoter mainly in an
insoluble form
Based on the luciferase activity measurements over 800
times more XylS was expressed from the T7 promoter
than from Ps2. If previous estimates of about 200 mole-
cules per cell [5] are reasonably close to the true value,
simple calculations indicated that an over 800-fold in-
crease would yield a band directly visible on SDS-PAGE.
A bacterial cell culture containing plasmid pET16.xylS
was split into two such that one was induced by IPTG
(0.5 mM), the other was not. Cells were harvested by
centrifugation, lysed and split into a soluble and an in-
soluble fraction by centrifugation and the resulting sam-
ples were separated on an SDS-PAGE gel. Inspection of
the band patterns (Figure 5) clearly demonstrated a
unique and strong band in only the sample from the in-
duced insoluble fraction. The distance of migration also
matched to the expected position for XylS (36 kDa). The
weaker band representing a similar size protein in the
insoluble fraction of the uninduced culture seems to ori-
ginate from a host-derived protein, as the same band
was observed for samples from cells containing plasmid
without xylS both in the presence and absence of in-
ducer (data not shown). Thus, the vast majority of the
XylS protein expressed from pET16.xylS is produced in
an aggregated and presumably inactive form.
Model for activation of Pm by XylS
The observations reported here are consistent with and
extend previous knowledge related to XylS function, and
together they support the following model:
In the absence of m-toluate XylS is mainly present in a
monomeric state, which probably is not able to activate
Pm, while in the presence of m-toluate an unknown
fraction of these monomers are converted to dimers,which activate transcription from Pm [5,6]. At low XylS
concentrations formation of active dimers probably de-
pends on m-toluate concentrations (Figure 6a), and this
assumption can explain the well known fact that expres-
sion from Pm correlates with the concentration of in-
ducer at fixed levels of XylS expression (usually from
Ps2). In contrast, above a certain threshold value for
XylS expression (illustrated in Figure 6b) the activity
from Pm does not increase any further, and this can be
explained by formation of XylS in a third state, as aggre-
gated and not active molecules (Figure 6c). Alternatively,
the threshold value might also be caused by saturation
of the Pm targets available in the cell. However, this ex-
planation does not fit with the observation that introduc-
tion of more Pm copies does not lead to a corresponding
stimulation of expression even if total XylS levels are in-
creased beyond the threshold value (Figure 3). Therefore,
the upper maximum level of active dimers in the cells
seems to be the result of inherent properties of the XylS
molecule itself.
The XylS variant StEP-13 is interesting in that it was
previously found to strongly stimulate expression levels
Figure 6 Visualization of the hypothesis explaining XylS behaviour at various intracellular concentrations. The numbers of DNA or XylS
molecules are not meant to represent the actual numbers in the cells. Only aggregates formed from active dimers of the protein are considered.
At low XylS concentrations a certain percentage of the dimerized XylS molecules will activate transcription (a); the amount of activated Pm
promoters will increase proportionally to XylS amounts up to a certain treshold value (b); when the threshold value is exceeded, XylS dimers will
aggregate and become inactive, while the amount of active dimers remains constant (c). For StEP-13 a higher percentage of XylS molecules will
dimerize at low XylS concentrations, resulting in more transcribed DNA (d); when the saturating concentration for wild type XylS is reached, there
will already be some aggregation of dimers in case of StEP-13 (e), and as for wild type this will increase further as more XylS is expressed (f). In
the absence of m-toluate, only a very small fraction of the XylS molecules will form dimers and these will activate transcription from Pm,
aggregation does not start at the XylS expression levels depicted here (g, h, i).
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ferred study the regulator was expressed from Ps2, now
known to produce only sub-saturating concentrations of
XylS with respect to activation of Pm. It is therefore in-
teresting that the experiments reported here show that
when the expression level of StEP-13 was increased the
maximum out-put from Pm was near the same as for
wild type XylS. According to the reasoning above this
seems to mean that StEP-13 is not able to form higher
concentrations of active dimers than wild type XylS, but
it reaches the maximum at lower inducer (m-toluate) or
regulator concentrations (Figure 6d-e). StEP-13 was gen-
erated by complex mutagenesis procedures that may
have changed its functional properties in more than one
way. This prediction fits with the observation that it re-
sponds more efficiently to low inducer concentrations,
while it is also more active in the absence of m-toluate.
Both observations are in agreement with an inherently
more efficient ability to form dimers, both in theabsence (see below) and presence of m-toluate. This
could involve higher affinity for the inducer, but no
change in the properties related to formation of higher
level aggregates from XylS dimers. Thus, more of the di-
mers would form aggregates at lower total XylS concen-
trations for StEP-13 than for the wild type protein, while
the maximum concentrations of active dimers would be
unchanged (Figure 6e-f ). Another possibility could be
that each dimer interacts more efficiently with RNAP,
but one might then predict that the maximum level of
expression from Pm would also be increased compared
to wild type XylS.
The behavior of XylS in the absence of inducer (m-tol-
uate) can be explained by the same model (Figure 6g-i).
Dimerization of the regulator is strongly stimulated in
the presence of inducer, but a certain low fraction of
XylS dimerizes also in the absence of inducer. However,
much higher total concentrations of the regulator are re-
quired before the maximum dimer concentration is reached.
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XylS expression levels.
If this model holds true it leads to an interesting pre-
diction that if one could mutagenize xylS, such that its
protein product could form higher concentrations of ac-
tive dimers (less aggregate formation), expression from
Pm could be further stimulated.
A screening for such variants should probably be done
under conditions of excessive amounts of XylS present
in the cells, to make sure that the desired phenotype is
actually detected. StEP-13 was identified while expressed
from Ps2 (and thus at low levels), and other types of var-
iants may then dominate the screening outcome.
Even though XylS is known to be produced at low
levels from its natural Ps2 promoter [5] these small
amounts are sufficient for successful applications of Pm
in recombinant protein production [24,25]. The results
reported here indicate that expression can be further
stimulated by increasing the intracellular concentration
of XylS, and by fine-tuning this level and expressing
XylS in trans the induction ratio can also be maximized.
As shown here this allowed for high expression levels
while maintaining an induction ratio of 700-fold, which
exceeds the reported induction ratios both reached by
5′-UTR variations [29] and by regulation of XylS expres-
sion by a promoter which is activated by the same in-
ducer as Pm [31].
In earlier studies a linear correlation between the copy
number of plasmids that carry the complete XylS/Pm
system and expression levels from Pm has been observed
[23-25]. It is common to assume that this well known ef-
fect is caused by increased dosage of the gene to be
expressed, but for a given XylS/Pm-based system the re-
sults presented here indicate that it is the increased
amounts of XylS that lead to more expression from Pm.
Fortunately the performance of the XylS/Pm system is
not limited exclusively by concentrations of XylS dimers,
since expression from Pm can be drastically stimulated
by using combinations of various types of mutations in
the expression cassette [28].
Conclusions
The earlier reported complete loss of inducibility of Pm
at high levels of XylS expression [21,30] can be ex-
plained by the existence of a maximum concentration of
active dimers inside the cell. An increase in XylS amounts
beyond the point at which this maximum concentration is
reached will lead to the formation of inactive aggregates.
For very high cell-internal XylS amounts the concentra-
tion of dimers will thus be the same under induced and
uninduced conditions. These findings enable expression of
the transcription factor at a level for which the induction
ratio at Pm is maximized, which is of high importance for
recombinant gene expression.Methods
Strains and growth conditions
The main bacterial strain used as host in this study was
Escherichia coli DH5α (Bethesda Research Laboratories),
unless otherwise stated. The cells were cultivated at
37°C in Lysogeny Broth (LB) (10 g L-1 tryptone, 5 g L-1
yeast extract, and 5 g L-1 NaCl) or on Lysogeny Agar
(LB broth with 20 g L-1 agar). Antibiotics concentra-
tions used in this study were: kanamycin 50 μg mL-1,
gentamicin 20 μg mL-1, and tetracycline 15 μg mL-1
(final concentration).
For luciferase enzyme assay measurements 10 mL of
LB were inoculated from an overnight culture and
grown at 37°C to an OD600 of 0.1 and then induced with
1 mMm-toluate. After induction cells were further incu-
bated at 30°C for 4 hours, before samples were collected.
When the T7 promoter was used, Escherichia coli
ER2566 (New England Biolabs) was used as a host.
Growth conditions were similar to those of DH5α, but
for induction IPTG was added to a final concentration
of 0.5 mM.
For induction of the ChnR/Pb system, cyclohexanone
was added at the concentrations indicated.
Standard DNA manipulations
All enzymes for DNA manipulations were purchased
from New England Biolabs and applied as described by
the manufacturers. Primers and oligonucleotides were
purchased either from Eurofins MWG Operon or Sigma
Genosys. Transformations in cloning experiments were
performed with a modified RbCl protocol (Promega).
For plasmid DNA purifications WizardPlus SV mini-
preps DNA purification kit (Promega) was used.
PCR-reactions were performed either by the Quik-
Change site-specific mutagenesis kit from Stratagene,
the Expand high fidelity PCR system kit from Roche or
the Phusion® High-Fidelity DNA Polymerase kit from
New England Biolabs, according to the manufacturer’s
recommendations.
Plasmid constructions and vector descriptions
The plasmid pTA13 [10] was used for construction of
pFS7. This plasmid harbours the Pm promoter with bla
as reporter gene and the gene coding for xylS behind the
natural Ps2 promoter in combination with a minimal
RK2 replicon. A new NdeI-site was introduced down-
stream of xylS by site-specific mutagenesis. The luc-gene
was amplified from pKT1 [29] with NdeI- and AgeI-
flanking ends and inserted downstream of xylS. The
NdeI-site was removed in a subsequent step by cloning
of a PCR-amplified NcoI-xylS-BbsI-fragment from pTA13
into the new vector. A spacer was inserted upstream of the
overlapping stop-start codon by site-specific mutagenesis
to eliminate the function of a potential Shine-Dalgarno site
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via site-specific mutagenesis or insertion of annealed oligo-
nucleotides upon digestion with suitable enzymes.
For construction of pFZ2A, xylS and its Ps2 promoter
were PCR-amplified with AgeI- and EcoRI-flanking sites
from pTA13 [10] and inserted into pBBR1-MCS-5 [33].
To obtain pFZ2B1 the Pb promoter part of pMS119
delta chnE [34] was PCR-amplified with BstZ171- and
NdeI- flanking ends and cloned into pTA16 [28]. The
chnR part of pMS119 delta chnE was PCR-amplified
with AgeI- and SacI-flanking ends and integrated into
the plasmid which already contained the Pb promoter.
The resulting plasmid was named pRL17A. xylS was
cloned behind the Pb promoter in this plasmid by diges-
tion with KpnI and NcoI. An XhoI-BamHI-fragment
was then cloned into vector pBBR1-MCS-5 [33], result-
ing in plasmid pFZ2B1.
In pFZ2B2 and pFZ2B3 the promoter in front of the gene
chnR, coding for the regulator protein of Pb in pFZ2B1,
was exchanged by two of the constitutive promoters
(Anderson-collection, BBa_J23105 = A, BBa_J23103 = B)
from the Registry of Standard Biological Parts [35]. For
this one-step sequence- and ligation-independent cloning
[38] was used. The two promoters increase levels of
ChnR and thus result in stimulated expression from Pb
(unpublished results).
pET16b.xylS is a plasmid based on pET16b (Novagen),
where the ampicillin resistance gene was exchanged by a
tetracycline resistance gene and xylS was inserted as
NdeI-BamHI fragment behind the T7 promoter.
pFS15 is a derivative of pTA13, where xylS has been
removed by digestion with AgeI and SacI and insertion
of a short linker.
Test of XylS expression via host ampicillin tolerance
To monitor changes in XylS expression indirectly, bla
under control of the Pm promoter was used as a re-
porter gene. Higher expression from Pm leads to in-
creased β-lactamase production and corresponding host
ampicillin tolerance in a nearly linear relationship with
the ampicillin concentrations used in this study [32].
Changes in XylS expression will consequently lead to
varying levels of expression from Pm in the presence of
m-toluate, which can easily be characterized by simply
plating cells on agar medium supplied with a gradient of
increasing levels of ampicillin. Thus the levels of bla-
expression will indirectly reflect the level of XylS being
expressed. For ampicillin tolerance testing cultures
were grown in LB medium in 96-well plates (at least
three replicates per sample) overnight, diluted in fresh
LB (1:104), plated on agar medium with a pin replica-
tor, and incubated at 30°C for 48 hours. The plates
were then inspected visually. The highest ampicillin
concentration on which growth occurred for the majorityof the replicates was treated as maximum ampicillin toler-
ance, while the lowest concentration in test at which no
growth was observable is indicated as error bar in the
corresponding figures. All ampicillin tolerance testing
experiments were performed at least twice. Ampicillin
concentrations varied from 5 μg mL-1 to 4500 μg mL-1.
Test of XylS expression levels using a synthetic operon
and luciferase assay
XylS amounts could be measured more directly via lucif-
erase activity in all constructs based on pFS7. Luciferase
activity was measured using the Luciferase Assay System
from Promega, according to the manufacturer’s protocol.
The luminometer used was a GloMax 20/20 (Promega).
Strains were grown as described above.
RNA isolation, cDNA synthesis and qRT-PCR
Transcript amounts were determined by two-step quan-
titative real-time reverse-transcriptase polymerase chain
reaction (qRT-PCR). RNAqueous (Ambion) was used for
total RNA isolation. Isolated RNA was treated with
Turbo DNAse (Ambion) and reverse transcription was
performed using a first-strand cDNA synthesis kit with
random pd(N)6 primers (Amersham Biosciences). PCR
was carried out in the presence of Power SYBR Green
PCR Master Mix (Applied Biosystems) using a 7500 Real
Time PCR system (Applied Biosystems). During PCR
samples were heated to 95°C for 10 min, followed by
40 cycles of amplification (95°C for 15 s; 60°C for
1 min). Results were analysed by 7500 system software
v1.3 using the 2-ΔΔCT method [39]. Primers were designed
using Primer Express software (Applied Biosystems). For
xylS primers 5′-TGTTATCATCTGCAAATAATACTCA
AAGG-3′ and 5′-GCCCGGCGCAAAATAGT-3′ were
used. 16S rRNA was used as endogenous control with
the primer pair 5′-ATTGACGTTACCCGCAGAAGAA-3′
and 5′-GCTTGCACCCTCCGTATTACC-3′.
Protein analysis by SDS-PAGE
For SDS-PAGE analysis cells were grown in a volume of
25 mL. Cultures containing plasmid pET16b.xylS were
induced with 0.5 mM IPTG or grown in the absence of
inducer. After centrifugation the pellets were washed in
0.9% NaCl. 100 mg pellet (wet weight) were resuspended
in 0.5 mL lysis buffer (50 mM Tris–HCl, pH 8.0, 1 mM
EDTA, pH 8.0, 20% sucrose), 1 mg lysozyme and 62.5
U mL-1 benzonase nuclease (Sigma) were added and
samples were left with shaking at room temperature
for 2 hours. After centrifugation (13.000 rpm, 8 min)
the supernatant was used as soluble fraction, while the
pellet was resuspended in 0.5 mL SDS-PAGE running
buffer, giving the insoluble fraction. Protein gels were
run under denaturing conditions using ClearPAGE 10%
gels and ClearPAGE SDS-R Run buffer (C.B.S. Scientific)
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(Merck).
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